ABSTRACT-Influences of drug-induced manipulations of central serotonergic function on lidocaine and pentylenetetrazol (PTZ)-induced convulsions were examined in mice. Agents that suppressed serotonergic transmission increased, whereas drugs that facilitated serotonin (5-HT) function decreased the incidence of lidocaine-induced convulsions. These treatments had similar influences on the incidence of PTZ-induced convulsions. Lidocaine (10-5-10-3 M) reduced the stimulation evoked [3H]5-HT release from cortical slices, followed with an increased spontaneous [3H] overflow at higher concentrations. These results may suggest that brain 5-HT neurons are causally involved as inhibitory neurons in lidocaine-induced convul sions as in the case of PTZ-induced convulsions.
Intravenously
infused local anesthetics have been shown to cause polyphasic actions on central nervous system (CNS) electrical activity (initially decrease, then increase and decrease and finally increase reticular neuro nal firing) in cats (1) . Stimulation of the CNS by local anesthetics is characterized by the activation of limbic dis charges, which is most striking in the amygdaloid nuclear complex, and the increase in metabolic activity, notable in the hippocampus (2, 3) . A major pharmacological sign of toxicity from local anesthetic administration is an exci tation of the CNS as in the development of general tonic clonic convulsions. It is generally agreed that local anesthetics induced convulsions by depressing inhibitory neurons, thereby permitting facilitation of excitatory neu rons, although the precise mechanism of convulsion in duction still remaines unsolved.
We have suggested that the inhibition of the function of r-aminobutyric acid (GABA) by local anesthetics through inhibiting GABA release from the neurons may be a major cause underlying the mechanisms of the induc tion of the convulsions (4). It is also suggested that brain monoamines such as norepinephrine, dopamine and serotonin (5-HT) serve as inhibitory neurotransmitters in several experimental models for convulsions. However, the stimulatory influence of brain catecholaminergic and serotonergic neurons on lidocaine-induced convulsions have been reported (5, 6) . Therefore, aminergic influences on local anesthetic-induced convulsions seem different from other drug-induced convulsion models. However, the causal relationship between brain 5-HT neurons and local anesthetic-induced convulsions is yet unclear.
The present study investigated the role of brain 5-HT neurons in local anesthetic-induced convulsions in com parison with that in PTZ-induced convulsions.
Male dd-strain mice weighing from 20 to 25 g were used. The injections of convulsants were performed be tween 2:00 PM and 5:00 PM because of the effects of cir cadian rhythms on these experiments. Animals had free access to food and water until 3 hr before the experi ments. p-Chlorophenylalanine (PCPA) was suspended in 0.3076 carboxymethylcellulose solution. Other drugs were dissolved in saline. Drugs were administered intraperitoneally at doses of 0,05 ml/10 g body weight. Equivalent volumes of vehicle were injected. Reserpine and PCPA were administered at 20 and 48 hr before the injection of convulsants or their sacrifice for the determina tion of amine content. Other drugs were administered at 30 min before the treatments. Convulsions induced by lidocaine were characterized by symptoms of ataxia, short loss of the righting reflex and clonic convulsions. The incidences of convulsions were obtained from the ap pearance of clonic convulsions for lidocaine and clonic tonic convulsions for PTZ as described previously (5) . The statistical analysis of significance of the difference in the incidence of convulsions was made by the chi square test. A dose of 70 mg/kg of lidocaine was used for the test of drugs which would decrease 5-HT function; and higher dosages, 80-90 mg/kg, were used for stimulants of 5-HT neurons. Dosages of PTZ were chosen to elicit similar effects. For determinations of the brain contents of 5-HT and 5-hydroxyindolacetic acid (5-HIAA), at the time cor responding to the administration of convulsants after vari ous treatments, the brain was isolated and homogenized in acidified butanol. 5-HT and 5-HIAA were extracted and determined fluorometrically by the methods of Cur zon and Green (7). Brain slices (0.3 mm in thickness, 3.0 mm-square) were pre-labeled by incubating for 60 min at 371C in an oxygenated solution of 143 mM NaCI, 6 mM KCI, 1.2 mM MgSO4i 1.3 mM CaCl2, 0.03 mM EDTA, 3 mM NaH2PO4, 10 mM glucose, 0.06 mM ascorbate, 5 nM pargyline and 10-' M [3H]5-HT (939.8 GBq/mM), pH 7.3. The slices were superfused in a plastic chamber, and the electrical field stimulation was performed for 1 min (2 msec, 20 mA, 5 Hz). The radioactivity in the superfusate was measured to determine 5-HT release. The P2-fraction from brain homogenate was prepared by the method of Gray and Whittaker (8) 5-HT for 10 min. The reaction was stopped by adding ice cold medium to the reaction mixture, which was then filtered through a glass micro-filter. 5-HT uptake was de termined by measuring the radioactivity on the filter. Iden tification of unchanged [3H]5-HT was performed by thin layer chromatography, and the unchanged amine in the superfusate and tissue was found to account for 76 85 % of the total radioactivity.
The effects of drug-induced manipulations of central serotonergic transmission on the incidence of lidocaine and PTZ-induced convulsions in mice were examined (Table 1) . Reserpine (20 mg/kg) reduced the brain 5-HT content: 5-HT contents in the cerebral mantle, cerebellum and brain stem were 0.42±0.02, 0.43±0.03, and 0.82±0.04,ig/g tissue in the control and 0.25±0.01, 0.17--1-0.01 and 0.49-L0.03 pg/g tissue in the reserpine treated mice, respectively, n=7. In the reserpine-treated mice, the incidence of lidocaine and PTZ-induced convul sions increased, although the differences were not statisti cally significant. PCPA (300 mg/kg), an inhibitor of tryp tophan-5-hydroxylase, reduced brain 5-HT and 5-HIAA (data not shown). In PCPA-treated mice, both incidences of lidocaine and PTZ-induced convulsions significantly increased. Methiothepin, a relatively selective 5-HT, receptor antagonist, but not methysergide, a 5-HT2-recep Table 1 .
Effects of various drugs on the incidence of lidocaine and PTZ-induced con vulsions in mice for antagonist, significantly increased the incidence of lidocaine-induced convulsions and slightly increased the incidence of PTZ-induced convulsions. These results may suggest that the disturbance of 5-HT neurons results in an increase in the incidence of lidocaine-induced convul sions, and thus 5-HT neurons have an inhibitory influ ence on lidocaine-induced convulsions. The 5-HT,-recep tor subtype may play an important role in the production of the 5-HT effect on the convulsions. Recent studies rev ealed the presence of 5-HT3-receptor subtype within dis crete areas of the CNS, which modulates neurotransmit ter release; e.g., stimulation of GABA release and inhibi tion of acetylcholine or norepinephrine release (9) . It is im portant to further evaluate the critical role of 5-HT-recep tor subtypes for understanding the serotonergic function in local anesthetic-induced convulsions.
The effects of treatments that would stimulate the activ ity of 5-HT neurons on the incidence of convulsions were next examined. In mice treated with 80 mg/kg of 5 hydroxytryptophan (5-HTP), a precursor of 5-HT, the brain content of 5-HT markedly increased: 5-HT contents in the cerebral mantle, cerebellum and brain stem were 0.43±0.08, 0.23±0.06 and 0.64±0.14 ug/g in the con trol and 1.18± 0.27, 1. (10), but decrease the threshold for hexafluorodiethylether-induced convulsions (11) . Seroto nergic causes of tremor and convulsions induced by nico tine in combination with pilocarpine (12) and, on the other hand, 5-HT-mediation of the protective effect of cloni dine against PTZ-induced convulsions (13) have been reported. Yoshimura et al. (5) also reported the stimulato ry influence of brain adrenergic neurons on lidocaine-in duced convulsions, which is the opposite of the generally accepted, inhibitory role of the neurons in local anesthet ic-induced convulsions. Although the reason for these dis crepancies about the aminergic influence on drug-induced convulsion is not known, the difference of 5-HT influence on lidocaine-induced convulsions does not seem merely due to the difference in the experimental models, because the results in PTZ-induced convulsions performed in the present study as a reference model well agree with the reported results. However, we can not fully rule out the possibility that the occurrence or involvement of some, recently presumed factor(s), such as endogenous imipra mine-like substance, may be different among the various experimental models or conditions. Fluoxetine, an anti depressant and an inhibitor of 5-HT reuptake, is an effec tive anticonvulsant in genetically epilepsy-prone rats, and a close relationship between the effects of the drug on serotonergic neurons and its anticonvulsant effect has been suggested (14) . Giround et al. (15) found a close cor relation between the reduction of 5-HIAA concentration in the cerebrospinal fluid (CSF) and thermal epilepsy in humans, and suggested that the reduction of 5-HIAA could be a biological index for the disease. These evidence suggest that serotonergic neurons are important regula tors of seizure and support the hypothesis for the inhibi tory role of 5-HT in the etiology of convulsions.
Lidocaine was shown to inhibit 5-HT release from corti cal slices in the present study (Fig. 1) . Also, lidocaine in higher concentrations (more than 3 x 10-4 M) increased spontaneous [3H] overflow, suggesting the inhibition of 5 HT reuptake into nerve terminals (Fig. 1) , and significant ly inhibited [3H]5-HT uptake into the P2-fraction (° inhi bition was 20.4±3.1% at 10-3 M n=5). Stimulation evoked 5-HT release was almost abolished under these conditions (Fig. 1) . Thus lidocaine could disarrange the inhibitory role of 5-HT neurons. This may be causally in volved in lidocaine-induced convulsions. Inhibitors of GABA synthesis and its receptors are potent convulsants, but perturbants of amines are not. Therefore, the GABAergic system may be one of the major targets for local anesthetics in the production of convulsions. The relief from 5-HT-inhibition by local anesthetics would augment the primary mechanisms to produce the convul sions. PTZ shares the GABAergic mechanism in its production of convulsions. The present and previous results from this laboratory (5) show that serotonergic and noradrenergic neurons are both inhibitory in PTZ-in duced convulsions, whereas noradrenergic neurons are ex citatory in lidocaine-induced convulsions, suggesting the difference in the mechanism for induction of convulsions by these two convulsants. 
